Abstract
Background: The worldwide incidence of Chronic Kidney Disease (CKD) is quickly expanding and has emerged as a major public health issue. According to studies, cardiovascular events account for more than half of all deaths in CKD patients. Serum magnesium protects the cardiovascular system in patients with CKD and Maintenance Hemodialysis (MHD). The aim of this study was to compare the Serum magnesium level among patients with chronic kidney diseases and patients with Maintenance Hemodialysis. Material & Methods: This was a cross-sectional study and was conducted in the Department of Biochemistry, Dhaka Medical College, Dhaka, Bangladesh during the period from July 2014 to June 2015. In our study, we took 50 diagnosed cases of CKD patients (Stage IV & V) and 50 CKD patients with MHD admitted to the Department of Nephrology, Dhaka Medical College Hospital. Results: In our study, we found the mean ±SD age was 43.86 ±9.21, and 47.14 ±9.02 in CKD, and CKD ē MHD respectively. BMI was almost similar in all groups. We found the mean ± SD of serum magnesium was 3.00 ± 0.33 mg/dl, and 2.02± 0.61 mg/dl in CKD, CKD ē MHD respectively. Serum magnesium was significantly higher in CKD than in CKD with MHD patients. Conclusions: From the findings of our study, it is concluded that serum magnesium level is increased in patients with CKD (CKD Stage IV & V) than in patients with maintenance hemodialysis. Serum magnesium levels should be checked on a regular basis in CKD and MHD patients in order to prevent cardiovascular and cerebrovascular illness caused by hypomagnesemia.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call